HealthQuill Articles by: HealthQuill
Austria’s Cyprumed GmbH has announced a license and option agreement with Merck & Co., to develop oral formulations of the US-based company’s peptides for an upfront payment of $493 million.
Drugs Health Medical

Austria’s Cyprumed in $493 million pact with Merck to develop peptides

HQ Team April 17, 2025: Austria’s Cyprumed GmbH has announced a license and option agreement with Merck & Co., to develop oral formulations

Read More
An oral antibiotic, gepotidacin, has shown efficacy in fighting gonorrhoea — one of the most prevalent sexually transmitted infections in the world, according to the results of an end-stage study published in The Lancet.
Drugs Health Research

Oral antibiotic shows efficacy in end-stage trials to treat gonorrhoea

HQ Team April 16, 2025: An oral antibiotic, gepotidacin, has shown efficacy in fighting gonorrhoea — one of the most prevalent sexually transmitted

Read More
Eisai Co., Ltd. and Biogen Inc.’s drug to treat Alzheimer’s disease got marketing authorisation in the European Union, according to a joint statement from the companies.
Drugs Health Pharma

Eisai Co, Biogen Inc.’s Alzheimer’s drug gets EU’s marketing approval

HQ Team April 16, 2025: Eisai Co., Ltd. and Biogen Inc.’s drug to treat Alzheimer’s disease got marketing authorisation in the European Union,

Read More
The 194 Member States of the WHO have reached a consensus on a draft agreement to strengthen global collaboration on prevention, preparedness and response to future pandemic threats.
Drugs Health Pharma

WHO’s Pandemic Agreement reaches consensus, may be adopted in May

HQ Team April 16, 2025: The 194 Member States of the WHO have reached a consensus on a draft agreement to strengthen global

Read More
Using artificial intelligence Stanford researchers have developed a “digital twin” of a part of a mouse brain that processes visual information.
Drugs Health Pharma

Stanford researchers build ‘digital twin’ of a part of mouse brain

HQ Team April 15, 2025: Using artificial intelligence Stanford researchers have developed a “digital twin” of a part of a mouse brain that

Read More
Harvard University has rejected demands from US President Donald Trump’s administration that threaten $9 billion in research funding.
Drugs Health Pharma

Harvard rejects Trump’s demands that threaten $9b research funding

HQ Team April 15, 2025: Harvard University has rejected demands from US President Donald Trump’s administration that threaten $9 billion in research funding.

Read More
Pfizer Inc. stopped its trial of danuglipron for treating chronic weight management after an asymptomatic patient developed a drug-induced liver injury that was resolved after discontinuation of the oral drug.
Uncategorized

Pfizer stops development of an investigational drug to treat obesity

HQ Team April 15, 2025: Pfizer Inc. stopped its trial of danuglipron for treating chronic weight management after an asymptomatic patient developed a

Read More
Bristol Myers Squibb’s end-phase trial to test a drug for treating a heart condition, where the muscle of the heart's main pumping chamber becomes abnormally thickened, has failed to meet its goals.
Drugs Health Medical

Bristol Myers’ test drug to treat a type of heart disease fails to meet goals

HQ Team April 15, 2025: Bristol Myers Squibb’s end-phase trial to test a drug for treating a heart condition, where the muscle of

Read More
Cambridge researchers have invented a device to record heart sounds accurately and diagnose coronary valve diseases better than traditional stethoscopes.
Health Medical Pharma

Cambridge develops handheld device to detect faulty heart valves

HQ Team April 13, 2025: Cambridge researchers have invented a device to record heart sounds accurately and diagnose coronary valve diseases better than

Read More
Johnson & Johnson MedTech’s arm, Shockwave Medical Inc. has started human trials to assess the effectiveness of its coronary intravascular catheter for treating blocked arteries, according to a statement.
Health Medical Pharma

J&J starts trial on coronary pressure wave catheter to clear artery blocks

HQ Team April 13, 2025: Johnson & Johnson MedTech’s arm, Shockwave Medical Inc. has started human trials to assess the effectiveness of its

Read More